ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Profitable Stocks We Keep Off Our Radar

NWSA Cover Image

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here are three profitable companies to avoid and some better opportunities instead.

News Corp (NWSA)

Trailing 12-Month GAAP Operating Margin: 11.6%

Established in 2013 after a restructuring, News Corp (NASDAQ: NWSA) is a multinational conglomerate known for its news publishing, broadcasting, digital media, and book publishing.

Why Do We Steer Clear of NWSA?

  1. Sales were flat over the last five years, indicating it’s failed to expand its business
  2. Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 7.3% for the last two years
  3. ROIC hasn’t moved, making investors question whether its recent investments can increase profitability

News Corp is trading at $23.70 per share, or 19.7x forward P/E. To fully understand why you should be careful with NWSA, check out our full research report (it’s free).

ICU Medical (ICUI)

Trailing 12-Month GAAP Operating Margin: 4.9%

Founded in 1984 and named for its initial focus on intensive care units, ICU Medical (NASDAQ: ICUI) develops and manufactures medical products for infusion therapy, vascular access, and vital care applications used in hospitals and other healthcare settings.

Why Does ICUI Give Us Pause?

  1. Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
  2. Forecasted revenue decline of 1.8% for the upcoming 12 months implies demand will fall off a cliff
  3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 11.1 percentage points

ICU Medical’s stock price of $125.99 implies a valuation ratio of 15.9x forward P/E. Read our free research report to see why you should think twice about including ICUI in your portfolio.

Kinder Morgan (KMI)

Trailing 12-Month GAAP Operating Margin: 27.9%

Operating what amounts to the toll roads of the energy industry, Kinder Morgan (NYSE: KMI) transports natural gas, refined petroleum products, and crude oil through its pipeline network across North America.

Why Are We Hesitant About KMI?

  1. Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 7.7% over the last five years was below our standards for the energy upstream and integrated energy sector

At $33.35 per share, Kinder Morgan trades at 24.3x forward P/E. Dive into our free research report to see why there are better opportunities than KMI.

Stocks We Like More

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  215.20
+0.00 (0.00%)
AAPL  254.23
+0.00 (0.00%)
AMD  196.31
+0.00 (0.00%)
BAC  47.28
+0.00 (0.00%)
GOOG  309.41
+0.00 (0.00%)
META  622.66
+0.00 (0.00%)
MSFT  399.41
+0.00 (0.00%)
NVDA  181.93
+0.00 (0.00%)
ORCL  154.69
+0.00 (0.00%)
TSLA  399.27
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.